Not all patients with CLL involve therapy. Regardless of all current advances, the iwCLL nevertheless recommends watchful observation for sufferers with asymptomatic disorder.86 This suggestion is based on at the least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (F